| Miss Angela Morena Rios I, RN,NP | |
|
1000 W Carson St, Torrance, CA 90502-2004 | |
| (310) 222-3528 | |
| Not Available |
| Full Name | Miss Angela Morena Rios I |
|---|---|
| Gender | Female |
| Speciality | General Practice |
| Location | 1000 W Carson St, Torrance, California |
| Accepts Medicare Assignments | Medicare enrolled and may accept medicare through third-party reassignment. May prescribe medicare part D drugs. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1316454507 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 208D00000X | General Practice | NP95008200 (California) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| Miss Angela Morena Rios I, RN,NP 751 W 129th St, Gardena, CA 90247-1701 Ph: (310) 494-1701 | Miss Angela Morena Rios I, RN,NP 1000 W Carson St, Torrance, CA 90502-2004 Ph: (310) 222-3528 |
News Archive
AVEO Pharmaceuticals, Inc., a biopharmaceutical company focused on discovering, developing and commercializing cancer therapeutics, today announced that new clinical data from a Phase 1b trial evaluating the company's lead product candidate, tivozanib, a highly potent and selective inhibitor of VEGF receptors 1, 2, and 3, in combination with paclitaxel (Taxol), a standard chemotherapy regimen, will be presented during the 33rd Annual San Antonio Breast Cancer Symposium (SABCS) being held December 8-12, 2010 at the Henry B. Gonzalez Convention Center in San Antonio, Texas.
Boehringer Ingelheim today announced data from Phase 2 and Phase 3 studies from the Company's ongoing clinical trial program investigating the efficacy and safety of tiotropium in asthma. These data were presented at the American Thoracic Society International Conference in Philadelphia, Pennsylvania.
For 17 years, Chalfonte LeNee Queen suffered periodic episodes of violent retching and abdominal pain that would knock her off her feet for days, sometimes leaving her writhing on the floor in pain.
Having above optimal levels of risk factors for heart disease between the ages of 18 and 30 can mean a two to three times greater risk of later developing coronary calcium, a strong predictor of heart disease, according to results of a new study from the National Heart, Lung, and Blood Institute (NHLBI) of the National Institutes of Health.
Scientists are reporting two findings that could influence the way researchers screen for, treat and assess prognosis for women with locally advanced breast cancer, an aggressive form of the disease. One finding offers a critical message regarding treatment strategy, they say.
› Verified 3 days ago
Katayoun K Mostafaie, M.D. General Practice Medicare: Medicare Enrolled Practice Location: 21840 Normandie Ave, Ste. 700, Torrance, CA 90502 Phone: 310-222-5101 Fax: 310-320-5463 | |
Mark T. Munekata, M.D. General Practice Medicare: Medicare Enrolled Practice Location: 21840 Normandie Ave, Ste. 700, Torrance, CA 90502 Phone: 310-222-5101 Fax: 310-320-5463 | |
Ella Ishaaya, General Practice Medicare: Not Enrolled in Medicare Practice Location: 1000 W Carson St, Torrance, CA 90502 Phone: 310-913-3890 | |
Michael Sassounian, General Practice Medicare: Medicare Enrolled Practice Location: 1000 W Carson St, Torrance, CA 90502 Phone: 310-222-2345 | |
Darrell W Harrington, M.D. General Practice Medicare: Medicare Enrolled Practice Location: 21840 Normandie Ave, Ste. 700, Torrance, CA 90502 Phone: 310-222-5101 Fax: 310-320-5463 | |
Eric P Brass, MD General Practice Medicare: Not Enrolled in Medicare Practice Location: 21840 Normandie Ave, Torrance, CA 90502 Phone: 310-222-5101 Fax: 310-320-5463 | |
Karen W Kwan, M.D. General Practice Medicare: Accepting Medicare Assignments Practice Location: 1000 W Carson St, Box 480, Torrance, CA 90502 Phone: 310-222-2465 Fax: 310-328-6837 |